Danbury, Connecticut-based IMS Health, a multinational big data and analytics company, has partnered with Quantia, developer of a web and mobile community for physicians. Through this partnership, ...
Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...
Health IT vendor IMS Health and biopharmaceutical research firm Quintiles Transnational Holdings have agreed to merge. Per the agreement, the companies will be combined in an all-stock merger of ...
The company's intangible assets--its proprietary data sets, technology, expertise, and reputation--place Quintiles IMS well ahead of its closest competitors. IMS Health's legacy business compiles ...
IMS Health filed for an initial public offering last week, which may raise as much as $1 billion for the healthcare data and consulting firm. IMS Health was acquired in 2010 by private equity firms ...
DANBURY, Conn. (AP) — IMS Health has raised $1.3 billion from an initial public offering of 65 million shares. The Danbury, Conn.-based company, which provides healthcare data and consulting services ...
Norwalk-based IMS Health Inc., a provider of market data to drugmakers, persuaded a federal appeals court to throw out Vermont's law barring the use of information about doctors' drug-prescribing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results